Serina Therapeutics, Inc. - SER
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jul 09, 2026 | — | P | A | 1,000.0 | 2.03 | 2,030.0 | 1,000.0 | View | |
| Jun 22, 2026 | — | C | D | 96,525.0 | 2.25 | 217,181.25 | 0.0 | View | |
| Jun 22, 2026 | — | A | A | 15,250.0 | 0.0 | 0.0 | 15,250.0 | View | |
| Jun 22, 2026 | — | C | A | 224,152.0 | 2.25 | 504,342.0 | 231,705.0 | View | |
| Jun 22, 2026 | — | P | A | 589.0 | 1.78 | 1,048.42 | 589.0 | View | |
| Jun 22, 2026 | — | C | D | 762,548.0 | 2.25 | 1,715,733.0 | 0.0 | View | |
| Jun 22, 2026 | — | A | A | 3,333,333.0 | 0.0 | 0.0 | 3,333,333.0 | View | |
| Jun 22, 2026 | — | A | A | 15,250.0 | 0.0 | 0.0 | 15,250.0 | View | |
| Jun 22, 2026 | — | C | A | 6,666,667.0 | 2.2499 | 14,999,334.08 | 8,564,382.0 | View | |
| Jun 22, 2026 | — | C | A | 1,770,805.0 | 2.25 | 3,984,311.25 | 1,897,445.0 | View | |
| Jun 22, 2026 | — | A | A | 15,250.0 | 0.0 | 0.0 | 15,250.0 | View | |
| Jun 22, 2026 | — | A | A | 15,250.0 | 0.0 | 0.0 | 15,250.0 | View | |
| Jun 22, 2026 | — | A | A | 15,250.0 | 0.0 | 0.0 | 15,250.0 | View | |
| Jun 15, 2026 | — | P | A | 5,000.0 | 1.77 | 8,850.0 | 10,100.0 | View | |
| Jun 15, 2026 | — | P | A | 5,100.0 | 1.745 | 8,899.5 | 5,100.0 | View | |
| May 27, 2026 | Chief Executive Officer | A | A | 10,100.0 | 1.93 | 19,493.0 | 10,100.0 | View | |
| May 26, 2026 | SVP, CMC & Formulation | A | A | 85,558.0 | 0.0 | 0.0 | 85,558.0 | View | |
| May 26, 2026 | Chief Executive Officer | A | A | 380,825.0 | 0.0 | 0.0 | 380,825.0 | View | |
| May 26, 2026 | Chief Financial Officer | A | A | 123,019.0 | 0.0 | 0.0 | 123,019.0 | View | |
| May 26, 2026 | Chief Scientific Officer | A | A | 85,558.0 | 0.0 | 0.0 | 85,558.0 | View | |
| May 26, 2026 | — | P | A | 10,000.0 | 1.93 | 19,300.0 | 20,000.0 | View | |
| May 26, 2026 | — | P | A | 10,000.0 | 1.77 | 17,700.0 | 10,000.0 | View | |
| May 22, 2026 | — | P | A | 12,183.0 | 1.65 | 20,101.95 | 12,183.0 | View | |
| Apr 21, 2026 | — | A | A | 59,667.0 | 1.94 | 115,753.98 | 126,910.0 | View | |
| Apr 21, 2026 | — | A | A | 7,553.0 | 1.94 | 14,652.82 | 7,553.0 | View | |
| Mar 24, 2026 | Chief Scientific Officer | M | D | 6,500.0 | 0.0 | 0.0 | 267,686.0 | View | |
| Mar 24, 2026 | Chief Scientific Officer | S | D | 6,500.0 | 2.8566 | 18,567.9 | 0.0 | View | |
| Mar 24, 2026 | Chief Scientific Officer | M | A | 6,500.0 | 0.06 | 390.0 | 6,500.0 | View | |
| Mar 20, 2026 | Chief Scientific Officer | M | D | 39,000.0 | 0.0 | 0.0 | 274,186.0 | View | |
| Mar 20, 2026 | Chief Scientific Officer | S | D | 39,000.0 | 2.5 | 97,500.0 | 0.0 | View | |
| Mar 20, 2026 | Chief Scientific Officer | M | A | 39,000.0 | 0.06 | 2,340.0 | 39,000.0 | View | |
| Feb 17, 2026 | — | A | A | 92,000.0 | 0.0 | 0.0 | 92,000.0 | View | |
| Feb 17, 2026 | SVP, CMC & Formulation | A | A | 69,000.0 | 0.0 | 0.0 | 69,000.0 | View | |
| Feb 17, 2026 | Chief Scientific Officer | A | A | 69,000.0 | 0.0 | 0.0 | 69,000.0 | View | |
| Feb 17, 2026 | Chief Executive Officer | A | A | 230,100.0 | 0.0 | 0.0 | 230,100.0 | View |